Clinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort.

Autor: Nichols CN; Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Lustberg M; Division of Infectious Diseases, Yale New Haven Hospital, New Haven, CT, USA., Sobhanie MME; Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Niermann LJ; Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Gordon M; Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Kman N; Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Parsons J; Department of Internal Medicine, Division of Pulmonary Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Conroy M; Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Dick M; Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Allen J; Department of Internal Medicine, Division of Pulmonary Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Reed E; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Lehman J; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, OH, USA., Malvestutto C; Department of Internal Medicine, Division of Infectious Diseases, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Publikováno v: Antiviral therapy [Antivir Ther] 2024 Aug; Vol. 29 (4), pp. 13596535241264694.

Clinical Outcomes With Definitive Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia With Retained Daptomycin and Ceftaroline Combination Therapy vs De-escalation to Monotherapy With Vancomycin, Daptomycin, or Ceftaroline.

Autor: Nichols CN; Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Wardlow LC; Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Coe KE; Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA., Sobhanie MME; Division of Infectious Diseases, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.

Publikováno v: Open forum infectious diseases [Open Forum Infect Dis] 2021 Jun 22; Vol. 8 (7), pp. ofab327. Date of Electronic Publication: 2021 Jun 22 (Print Publication: 2021).

Phenotypic and genotypic characteristics of mecA - positive oxacillin-sensitive Staphylococcus aureus isolated from patients with bloodstream infection in a tertiary hospital in Southern Brazil.

Autor: Duarte, Felipe Crepaldi, Olak, Anna Paula Silva, Cardim, Stefani Lino, Danelli, Tiago, Magalhães, Gerusa Luciana Gomes, Oliveira, Deisy Mara Lima de, Pimenta, Julia da Silva, Vespero, Eliana Carolina, Yamada-Ogatta, Sueli Fumie, Perugini, Marcia Regina Eches

Publikováno v: Brazilian Journal of Microbiology; Sep2024, Vol. 55 Issue 3, p2705-2713, 9p

A Retrospective Cohort Study Comparing Dual Therapy With Ceftaroline With Vancomycin or Daptomycin Monotherapy for High-Grade or Persistent MRSA Bacteremia.

Autor: Cabanilla, M. Gabriela, Bernauer, Michael L., Briski, Matthew J., Atallah, Liana M., Koury, Jason, Thompson, Cecilia M., Rodriguez, Chelsea N., Jakeman, Bernadette, Byrd, Thomas F.

Publikováno v: Journal of Pharmacy Technology; Jun2024, Vol. 40 Issue 3, p134-141, 8p

Clinical characteristics and outcomes in pseudomonas endocarditis: a systematic review of individual cases : Systematic review of pseudomonas endocarditis.

Autor: Meena DS; Division of Infectious Diseases, Department of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, 342005, India. dsmims14@gmail.com., Kumar D; Division of Infectious Diseases, Department of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, 342005, India., Kumar B; Division of Infectious Diseases, Department of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, 342005, India., Bohra GK; Division of Infectious Diseases, Department of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, 342005, India., Midha N; Division of Infectious Diseases, Department of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, 342005, India., Garg MK; Division of Infectious Diseases, Department of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, 342005, India.

Publikováno v: Infection [Infection] 2024 Oct; Vol. 52 (5), pp. 2061-2069. Date of Electronic Publication: 2024 Jun 10.